Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 555 | 143 | 16 | 0 | 0 |
| Cost of Goods | 601 | 365 | 173 | N/A | N/A |
| Gross Profit | -46 | -222 | -157 | N/A | N/A |
| Operating Expenses | 6,799 | 8,911 | 8,447 | 7,523 | 5,257 |
| Operating Income | -6,244 | -8,768 | -8,431 | -7,523 | -5,257 |
| Interest Expense | 78 | 75 | 22 | -16 | -135 |
| Other Income | -461 | -265 | -374 | -447 | -103 |
| Pre-tax Income | -6,783 | -9,108 | -8,827 | -7,954 | -5,225 |
| Income Tax | N/A | N/A | -1,095 | N/A | N/A |
| Net Income Continuous | -6,783 | -9,108 | -7,732 | -7,954 | -5,225 |
| Net Income | $-6,783 | $-9,108 | $-7,732 | $-7,954 | $-5,225 |
| EPS Basic Total Ops | -2.00 | -2.80 | -2.60 | -3.20 | -2.00 |
| EPS Basic Continuous Ops | -2.02 | -2.77 | -2.52 | -3.00 | -2.01 |
| EPS Diluted Total Ops | -2.00 | -2.80 | -2.60 | -3.20 | -2.00 |
| EPS Diluted Continuous Ops | -2.02 | -2.77 | -2.52 | -3.00 | -2.01 |
| EBITDA(a) | $-5,139 | $-8,544 | $-8,133 | $-7,412 | $-5,155 |